FDA updates in urology: February 2025

A recap of the FDA submissions and regulatory decisions in urology from February 2025.

Welcome to Urology Times’® monthly FDA update! This month, key developments include advances in prostate and kidney cancer detection, as well as an emerging treatment option in primary hyperoxaluria 1 (PH1).